Prosecution Insights
Last updated: September 27, 2026
Application No. 18/962,908

FASTING-MIMICKING DIET (FMD) BUT NOT WATER-ONLY FASTING PROMOTES REVERSAL OF INFLAMMATION AND IBD PATHOLOGY

Non-Final OA §102
Filed
Nov 27, 2024
Priority
Mar 15, 2018 — provisional 62/643,296 +5 more
Examiner
GANGLE, BRIAN J
Art Unit
Tech Center
Assignee
University of Southern California
OA Round
1 (Non-Final)
77%
Grant Probability
Favorable
1-2
OA Rounds
9m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 77% — above average
77%
Career Allowance Rate
733 granted / 956 resolved
+16.7% vs TC avg
Moderate +15% lift
Without
With
+14.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
47 currently pending
Career history
996
Total Applications
across all art units

Statute-Specific Performance

§101
6.4%
-33.6% vs TC avg
§103
16.1%
-23.9% vs TC avg
§102
22.2%
-17.8% vs TC avg
§112
37.4%
-2.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 956 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group II in the reply filed on 8/24/2026 is acknowledged. Claims 17-28 are pending. Claims 17-25 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claims 26-28 are currently under examination. Information Disclosure Statement The information disclosure statement filed on 3/19/2025 has been considered. A signed copy is enclosed. Claim Objections Claims 27-28 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 26 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jones (US Patent Application Publication 2006/0112584). The instant claim is drawn to a dietary supplement comprising: a powdered vegetable mixture of beets, carrots, collard, spinach, kale, mushroom, tomato, and optionally nettle leaf, the powdered vegetable mixture being dehydrated to form a dried vegetable powder. Jones discloses dried powders comprising mixture of beets, carrots, collard, spinach, kale, mushroom, tomato, and nettle leaf (see paragraphs 0011 and 0013). Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Brian J Gangle whose telephone number is (571)272-1181. The examiner can normally be reached M-F, 9-6:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne Gussow can be reached at 571-272-6047. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRIAN GANGLE/Primary Examiner, Art Unit 1645
Read full office action

Prosecution Timeline

Nov 27, 2024
Application Filed
Sep 08, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12709731
METHOD OF PRODUCING BIOLOGICAL MATERIAL
2y 8m to grant Granted Aug 18, 2026
Patent 12702684
METHODS AND COMPOSITIONS FOR TREATING SKIN DISEASE WITH RECOMBINANT MICROORGANISMS
2y 9m to grant Granted Aug 11, 2026
Patent 12698328
NOVEL ANTIBODIES
3y 11m to grant Granted Aug 04, 2026
Patent 12685708
NOVEL SKIN CARE COMPOSITION
4y 3m to grant Granted Jul 21, 2026
Patent 12673074
A MYCOBACTERIUM FOR USE IN CANCER THERAPY
3y 2m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
77%
Grant Probability
91%
With Interview (+14.7%)
2y 7m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 956 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month